Overview

The American Academy of CME, Inc. (Academy) is a not-for-profit educational foundation focused on providing high-quality, certified continuing education activities that improve the competence of healthcare professionals and change their behavior to positively impact patient care. The Academy, along with the associations and medical education companies with which it partners, have developed educational activities for physicians specialists and primary care), nurses, pharmacists, registered dietitians, transplant coordinators, and social workers.

The Academy and its partners have extensive experience in the creation and execution of educational activities across multiple live and enduring formats for varied and diverse health care audiences. Our team includes both clinical specialists and professionals qualified in the practice of adult education, including development of gap analyses and instructional design, content development, meeting planning and execution, and outcomes measurement.


A Comprehensive Review of Metastatic Colorectal Cancer (mCRC) Management: An Interprofessional Approach to Care

Target Audience This activity is designed to meet the educational needs of oncologists, oncology nurses and pharmacists engaged in the care of patients with metastatic colorectal cancer. Program Overview This activity will address changes in treatment combinations and sequencing of regimens, as well as molecular markers that should be tested to guide therapy. Further, supportive care measur...
American Academy of CME

Ace the Case: Persistent Anemia in a Patient with Chronic Kidney Disease

Series of three online cases addressing key issues of anemia in CKD patients.
American Academy of CME

Ace the Case: Preventing the Old Man’s Friend in the Absence of Family Support (Part 2 of 3-part Series)

Vaccination is the best way to protect against influenza (flu) and possible complications, including pneumonia. Vaccination is especially important for people in groups that are at high risk for serious complications, hospitalization, or death. Physicians and pharmacists are poised to influence older adults’ decisions to become immunized against potentially preventable diseases. The underut...
American Academy of CME

Ace the Case: Shortness of Breath and Hospital Admittance. What Can I Really Do? (Part 3 of 3-part Series)

Vaccination is the best way to protect against influenza (flu) and possible complications, including pneumonia. Vaccination is especially important for people in groups that are at high risk for serious complications, hospitalization, or death. Physicians and pharmacists are poised to influence older adults’ decisions to become immunized against potentially preventable diseases. The underut...
American Academy of CME

Ace the Case: To Vaccinate or Not? Making the Determination for Older Adults (Part 1 of 3-part series)

Vaccination is the best way to protect against influenza (flu) and possible complications, including pneumonia. Vaccination is especially important for people in groups that are at high risk for serious complications, hospitalization, or death. Physicians and pharmacists are poised to influence older adults’ decisions to become immunized against potentially preventable diseases. The underut...
American Academy of CME

Best of ACTHIV 2022: Cardio-metabolic Complications of ART

This module will look at the epidemiology of cardiovascular disease in HIV, identify predictors of cardiometabolic risk of ART, and best practices the team can apply to the prevention and management of cardiometabolic risk in PWH. At the completion of this educational activity, participants will: Review the epidemiology of cardiovascular disease in HIV Identify predictors of cardiometabol...
American Academy of CME

Best of ACTHIV 2022: Case-Based Management of Hepatitis C in Persons with HIV

At the completion of this educational activity, participants will: Discuss pre-treatment Assessment, recommended regimens and on-treatment monitoring for simplified HCV treatment Discuss some real-world HCV treatment issues related to choice of direct-acting antiviral (DAA) therapy in HIV-HCV coinfected patients Identify relevant drug interactions of DAAs with antiretroviral therapy
American Academy of CME

Best of ACTHIV 2022: Dermatology for People with HIV

Description This module explores how to recognize and treat common HIV dermatologic diseases the care team may encounter in clinical practice. At the completion of this educational activity, participants will: Recognize and treat common HIV dermatologic diseases Apply lessons from global HIV dermatology to your practice setting
American Academy of CME

Best of ACTHIV 2022: Opportunistic Infection Cases in People with HIV

This module will provide an overview of opportunistic infections for the HIV care team. Part of the conference "HIV: the Basics" session, the module will explore what members of the care team should know about opportunistic infections. At the completion of this educational activity, participants will: Describe common opportunistic infections seen among persons with HIV Cite reas...
American Academy of CME

Best of ACTHIV 2022: Principles of Antiretroviral Therapy

This module will review the HIV life cycle and targets for current antiretroviral agents, considerations for choosing an ART regimen, and resistance testing methods. Part of the conference "HIV: the Basics" session, this module provides both a solid grounding for newer HIV clinicians and a review of foundational concepts for more experienced care team members. At the completion of t...
American Academy of CME

Best of ACTHIV 2022: Update on the Diagnosis and Treatment of STIs

This module will focus on the latest screening guidelines for common STIs among people with HIV, recommended strategies for diagnosing common STIs, and how you can work with your team to apply the 2021 CDC guidelines to practice. At the completion of this educational activity, participants will: Review the latest screening guidelines for common STIs among people with HIV. Utilize recommen...
American Academy of CME

DOACs and Older Adults with NVAF (Part 1 of 3)

Direct acting oral anti-coagulants (DOACs) are a newer class of medications with emerging clinical recommendations and evidence for safe use. Cardiologists and pharmacists have key roles to play as part of the care team to help ensure efficacy and safety of DOACs within the severely ill patient population.
American Academy of CME

DOACs and Patients with Renal Impairment (Part 2 of 3)

Direct acting oral anti-coagulants (DOACs) are a newer class of medications with emerging clinical recommendations and evidence for safe use. Cardiologists and pharmacists have key roles to play as part of the care team to help ensure efficacy and safety of DOACs within the severely ill patient population.
American Academy of CME

Interprofessional Perspectives on Managing Immune-Related Adverse Events

The development of immunotherapies, including ICIs and CAR-T cell agents, is improving survival for some patients with cancer, even in advanced cases. These agents are associated with novel irAEs that are monitored and managed differently than the more familiar standard chemotherapy toxicities. Collaboration among members of the oncology care team is necessary to ensure that all healthcare provi...
American Academy of CME

Key Questions Answered in the Management of Follicular Lymphoma

Advances in the treatment of FL have led to the approval of two novel agents and updates to clinical practice guidelines. Nurses have unique and often long-standing relationships with their patients who have FL and are trusted sources of information and support. Oncology nurses who care for patients with FL should be aware of treatment guideline changes and their impact on clinical practice. Rec...
American Academy of CME

Managing Clinical Expectations in Infections Due to Gram-Positive Bacteria

Activity Description The number of formally ID-trained pharmacists and physicians are limited across the country. This means that there is a growing role for general pharmacists and non-ID physicians to optimally manage their patients’ antibiotics in the hospital or outpatient setting as well as fulfill necessary expert roles in antibiotic stewardship programs. In order to do so, physicians a...
American Academy of CME

OACs and Patients with Malignancies (Part 3 of 3)

Direct acting oral anti-coagulants (DOACs) are a newer class of medications with emerging clinical recommendations and evidence for safe use. Cardiologists and pharmacists have key roles to play as part of the care team to help ensure efficacy and safety of DOACs within the severely ill patient population.
American Academy of CME

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map